TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial.

Samuel A Funt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.